Southfield-based fintech company Credibly has been issued a new patent (U.S. Patent No. US 12,505,113 B2) by the United States Patent and Trademark Office related to embedding generative AI and […] ...

From fine-tuning open source models to building agentic frameworks on top of them, the open source world is ripe with ...

We’re honored to welcome Tom and Ram to our advisory board. Their combined insights, from standards in verification and ...

Enterprises that continue to layer AI onto existing analytics frameworks will continue to see incremental gains. Those that ...

Apple has acquired an Israel-based AI startup called Q.ai, according to a new report from the Financial Times. The ...

BITS Pilani has launched 2 new courses on AI, Machine Learning and Cybersecurity. The enrolment process is ongoing on ...

As financial crime grows in scale, speed, and sophistication, banks are increasingly turning to artificial intelligence, ...

How do you translate ancient Palmyrene script from a Roman tombstone? How many paired tendons are supported by a specific sesamoid bone in a hummingbird? Can you identify closed syllables in Biblical ...

“To maximize the likelihood that applications and patents will be found eligible under Section 101 by the USPTO and courts [after Recentive], applicants should carefully craft a narrative of a ...

Moving from legacy, rules-based systems to AI-driven protection isn’t as simple as switching on new technology.

Raja Shankar, VP of machine learning at IQVIA, explains how AI-driven trial simulation and automation are beginning to influence decision-making across every phase of clinical development.